Carotid endarterectomy for symptomatic carotid stenosis
<p><strong>Background:</strong> Stroke is the third leading cause of death and the most common cause of long‐term disability. Severe narrowing (stenosis) of the carotid artery is an important cause of stroke. Surgical treatment (carotid endarterectomy) may reduce the risk of stroke...
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Cochrane Collaboration
2020
|
| _version_ | 1797077969598939136 |
|---|---|
| author | Rerkasem, A Orrapin, S Howard, DPJ Rerkasem, K |
| author_facet | Rerkasem, A Orrapin, S Howard, DPJ Rerkasem, K |
| author_sort | Rerkasem, A |
| collection | OXFORD |
| description | <p><strong>Background:</strong> Stroke is the third leading cause of death and the most common cause of long‐term disability. Severe narrowing (stenosis) of the carotid artery is an important cause of stroke. Surgical treatment (carotid endarterectomy) may reduce the risk of stroke, but carries a risk of operative complications. This is an update of a Cochrane Review, originally published in 1999, and most recently updated in 2017.</p>
<p><strong>Objectives:</strong> To determine the balance of benefit versus risk of endarterectomy plus best medical management compared with best medical management alone, in people with a recent symptomatic carotid stenosis (i.e. transient ischaemic attack (TIA) or non‐disabling stroke).</p>
<p><strong>Search Methods:</strong> We searched the Cochrane Stroke Group Trials Register, CENTRAL, MEDLINE Ovid, Embase Ovid, Web of Science Core Collection, ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform (ICTRP) portal to October 2019. We also reviewed the reference lists of all relevant studies and abstract books from research proceedings.</p>
<p><strong>Selection Criteria:</strong> We included randomised controlled trials (RCTs) comparing carotid artery surgery plus best medical treatment with best medical treatment alone.</p>
<p><strong>Data Collection and Analysis:</strong> Two review authors independently selected studies, assessed risk of bias, and extracted the data. We assessed the results and the quality of the evidence of the primary and secondary outcomes by the GRADE method, which classifies the quality of evidence as high, moderate, low, or very low.</p>
<p><strong>Main Results:</strong> We included three trials involving 6343 participants. The trials differed in the methods of measuring carotid stenosis and in the definition of stroke. Using the primary electronic data files, we pooled and analysed individual patient data on 6092 participants (35,000 patient‐years of follow‐up), after reassessing the carotid angiograms and outcomes from all three trials, and redefining outcome events where necessary, to achieve comparability.</p>
<p>Surgery increased the five‐year risk of any stroke or operative death in participants with less than 30% stenosis (risk ratio (RR) 1.25, 95% confidence interval (CI) 0.99 to 1.56; 2 studies, 1746 participants; high‐quality evidence). Surgery decreased the five‐year risk of any stroke or operative death in participants with 30% to 49% stenosis (RR 0.97, 95% CI 0.79 to 1.19; 2 studies, 1429 participants; high‐quality evidence), was of benefit in participants with 50% to 69% stenosis (RR 0.77, 95% CI 0.63 to 0.94; 3 studies, 1549 participants; moderate‐quality evidence), and was highly beneficial in participants with 70% to 99% stenosis without near‐occlusion (RR 0.53, 95% CI 0.42 to 0.67; 3 studies, 1095 participants; moderate‐quality evidence). However, surgery decreased the five‐year risk of any stroke or operative death in participants with near‐occlusions (RR 0.95, 95% CI 0.59 to 1.53; 2 studies, 271 participants; moderate‐quality evidence).</p>
<p><strong>Authors' Conclusions:</strong> Carotid endarterectomy reduced the risk of recurrent stroke for people with significant stenosis. Endarterectomy might be of some benefit for participants with 50% to 69% symptomatic stenosis (moderate‐quality evidence) and highly beneficial for those with 70% to 99% stenosis (moderate‐quality evidence).</p> |
| first_indexed | 2024-03-07T00:25:41Z |
| format | Journal article |
| id | oxford-uuid:7e0da1b7-592d-4ba0-959b-edb65c2c02ff |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T00:25:41Z |
| publishDate | 2020 |
| publisher | Cochrane Collaboration |
| record_format | dspace |
| spelling | oxford-uuid:7e0da1b7-592d-4ba0-959b-edb65c2c02ff2022-03-26T21:07:46ZCarotid endarterectomy for symptomatic carotid stenosisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7e0da1b7-592d-4ba0-959b-edb65c2c02ffEnglishSymplectic ElementsCochrane Collaboration2020Rerkasem, AOrrapin, SHoward, DPJRerkasem, K<p><strong>Background:</strong> Stroke is the third leading cause of death and the most common cause of long‐term disability. Severe narrowing (stenosis) of the carotid artery is an important cause of stroke. Surgical treatment (carotid endarterectomy) may reduce the risk of stroke, but carries a risk of operative complications. This is an update of a Cochrane Review, originally published in 1999, and most recently updated in 2017.</p> <p><strong>Objectives:</strong> To determine the balance of benefit versus risk of endarterectomy plus best medical management compared with best medical management alone, in people with a recent symptomatic carotid stenosis (i.e. transient ischaemic attack (TIA) or non‐disabling stroke).</p> <p><strong>Search Methods:</strong> We searched the Cochrane Stroke Group Trials Register, CENTRAL, MEDLINE Ovid, Embase Ovid, Web of Science Core Collection, ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform (ICTRP) portal to October 2019. We also reviewed the reference lists of all relevant studies and abstract books from research proceedings.</p> <p><strong>Selection Criteria:</strong> We included randomised controlled trials (RCTs) comparing carotid artery surgery plus best medical treatment with best medical treatment alone.</p> <p><strong>Data Collection and Analysis:</strong> Two review authors independently selected studies, assessed risk of bias, and extracted the data. We assessed the results and the quality of the evidence of the primary and secondary outcomes by the GRADE method, which classifies the quality of evidence as high, moderate, low, or very low.</p> <p><strong>Main Results:</strong> We included three trials involving 6343 participants. The trials differed in the methods of measuring carotid stenosis and in the definition of stroke. Using the primary electronic data files, we pooled and analysed individual patient data on 6092 participants (35,000 patient‐years of follow‐up), after reassessing the carotid angiograms and outcomes from all three trials, and redefining outcome events where necessary, to achieve comparability.</p> <p>Surgery increased the five‐year risk of any stroke or operative death in participants with less than 30% stenosis (risk ratio (RR) 1.25, 95% confidence interval (CI) 0.99 to 1.56; 2 studies, 1746 participants; high‐quality evidence). Surgery decreased the five‐year risk of any stroke or operative death in participants with 30% to 49% stenosis (RR 0.97, 95% CI 0.79 to 1.19; 2 studies, 1429 participants; high‐quality evidence), was of benefit in participants with 50% to 69% stenosis (RR 0.77, 95% CI 0.63 to 0.94; 3 studies, 1549 participants; moderate‐quality evidence), and was highly beneficial in participants with 70% to 99% stenosis without near‐occlusion (RR 0.53, 95% CI 0.42 to 0.67; 3 studies, 1095 participants; moderate‐quality evidence). However, surgery decreased the five‐year risk of any stroke or operative death in participants with near‐occlusions (RR 0.95, 95% CI 0.59 to 1.53; 2 studies, 271 participants; moderate‐quality evidence).</p> <p><strong>Authors' Conclusions:</strong> Carotid endarterectomy reduced the risk of recurrent stroke for people with significant stenosis. Endarterectomy might be of some benefit for participants with 50% to 69% symptomatic stenosis (moderate‐quality evidence) and highly beneficial for those with 70% to 99% stenosis (moderate‐quality evidence).</p> |
| spellingShingle | Rerkasem, A Orrapin, S Howard, DPJ Rerkasem, K Carotid endarterectomy for symptomatic carotid stenosis |
| title | Carotid endarterectomy for symptomatic carotid stenosis |
| title_full | Carotid endarterectomy for symptomatic carotid stenosis |
| title_fullStr | Carotid endarterectomy for symptomatic carotid stenosis |
| title_full_unstemmed | Carotid endarterectomy for symptomatic carotid stenosis |
| title_short | Carotid endarterectomy for symptomatic carotid stenosis |
| title_sort | carotid endarterectomy for symptomatic carotid stenosis |
| work_keys_str_mv | AT rerkasema carotidendarterectomyforsymptomaticcarotidstenosis AT orrapins carotidendarterectomyforsymptomaticcarotidstenosis AT howarddpj carotidendarterectomyforsymptomaticcarotidstenosis AT rerkasemk carotidendarterectomyforsymptomaticcarotidstenosis |